This article and associated images are based on a poster originally authored by Sophie O’Neil, Kyle Thompson, Rita Pereira, Emily Russell and Stuart McElroy and presented at ELRIG Drug Discovery 2025 ...
Shanghai Institutes for Biological Sciences and Shanghaitech University have identified dopamine D2 receptor and/or 5-HT receptor agonists reported to be useful for the treatment of depression and ...
Cybin Irl Ltd. has described phenethylamine compounds acting as 5-HT2 receptor agonists reported to be useful for the treatment of lung diseases, cardiovascular disorders, inflammatory disorders, ...
NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (DRUG), a pioneering company focused on developing highly selective 5-HT2 agonists for the treatment of drug-resistant ...
Interest in classical or serotonergic psychedelics has resurged, given their potential to induce rapid, sustained therapeutic effects. Psychedelics are limited by their hallucinogenic effects and can ...
NORTH CHICAGO, Ill., Oct. 17, 2025 /PRNewswire/-- AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of Gilgamesh Pharmaceuticals' lead investigational candidate, bretisilocin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results